Company intelligence / Profile preview

DrugCard

Ownership: Private
Development stage: Commercial

Overview

DrugCard is an AI-driven platform designed to automate and streamline local medical literature screening for pharmacovigilance. It enables pharmaceutical companies and CROs to efficiently monitor global medical journals in over 100 languages, providing instant notifications of new drug mentions and weekly summary reports. The solution claims significant time savings compared to manual processes—up to 10x faster—and supports regulatory compliance by ensuring comprehensive adverse event monitoring across diverse geographies. Its proprietary OCR technology allows accurate extraction from scanned or low-quality journal copies.

Industry: Biomedical IT and Biomedical Data Platforms

Beyond the preview

Go deeper on DrugCard.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on DrugCard.

Explore the full profile